The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Current and future antiplatelet therapies: emphasis on preserving haemostasis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Mehran, R., Rao, S. V., Bhatt, D. L., Gibson, C. M., Caixeta, A., Eikelboom, J., Kaul, S., Wiviott, S. D., Menon, V., Nikolsky, E., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.009449 · Cited by 4,476
(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,314
2014 ESC/EACTS Guidelines on myocardial revascularization
Kolh, P., Windecker, S., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu366 · Cited by 4,199
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Global atlas on cardiovascular disease prevention and control.
Mendis, S., Puska, P., & Norrving, B. G. (2011) · Virtual Defense Library (Ministerio de Defensa) · Cited by 3,440
Sleight, R. B., Sleight, P., Parish, S., Appleby, P. N., Collins, R., & Baigent, C. (1988) · PubMed · Cited by 2,868
Rivaroxaban with or without aspirin in stable cardiovascular disease
Eikelboom, J. W., Connolly, S. J., Bosch, J., Dagenais, G. R., Hart, R. G., Shestakovska, O., Diaz, R., Alings, M., Lonn, E. M., Anand, S. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709118 · Cited by 2,438
(2012) · RePEc: Research Papers in Economics · Cited by 1,951
Mechanisms of Thrombus Formation
Furie, B., & Furie, B. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801082 · Cited by 1,926
Lewis, H. D., Davis, J. W., Archibald, D. G., Steinke, W. E., Smitherman, T. C., Doherty, J. E., Schnaper, H. W., LeWinter, M. M., Linares, E., Pouget, J. M., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090703 · Cited by 1,709
Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000404 · Cited by 1,355
Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes
Eikelboom, J. W., Mehta, S. R., Anand, S. S., Xie, C., Fox, K. A. A., & Yusuf, S. (2006) · Circulation · doi:10.1161/circulationaha.106.612812 · Cited by 1,341
Protease‐activated receptors in hemostasis, thrombosis and vascular biology
COUGHLIN, S. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01377.x · Cited by 1,035
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
Morrow, D. A., Braunwald, E., Bonaca, M. P., Ameriso, S. F., Dalby, A. J., Fish, M. P., Fox, K. A. A., Lipka, L. J., Liu, X., Nicolau, J. C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200933 · Cited by 948
Signaling During Platelet Adhesion and Activation
Li, Z., Delaney, M. K., O'Brien, K. A., & Du, X. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207522 · Cited by 911
A shear gradient–dependent platelet aggregation mechanism drives thrombus formation
Nesbitt, W. S., Westein, E., Tovar-Lopez, F. J., Tolouei, E., Mitchell, A., Fu, J., Carberry, J., Fouras, A., & Jackson, S. P. (2009) · Nature Medicine · doi:10.1038/nm.1955 · Cited by 862
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events
Bhatt, D. L., Stone, G. W., Mahaffey, K. W., Gibson, C. M., Steg, P. G., Hamm, C. W., Price, M. J., Leonardi, S., Gallup, D., Bramucci, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300815 · Cited by 840
Mehta, S. R., Tanguay, J.-F., Eikelboom, J. W., Jolly, S. S., Joyner, C. D., Granger, C. B., Faxon, D. P., Rupprecht, H.-J., Budaj, A., Avezum, A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61088-4 · Cited by 825
Manoukian, S. V., Feit, F., Mehran, R., Voeltz, M. D., Ebrahimi, R., Hamon, M., Dangas, G. D., Lincoff, A. M., White, H. D., Moses, J. W., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.027 · Cited by 798
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Tricoci, P., Huang, Z., Held, C., Moliterno, D. J., Armstrong, P. W., Van de Werf, F., White, H. D., Aylward, P. E., Wallentin, L., Chen, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109719 · Cited by 754
Husted, S., Emanuelsson, H., Heptinstall, S., Sandset, P. M., Wickens, M., & Peters, G. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi754 · Cited by 743
Integrins: dynamic scaffolds for adhesion and signaling in platelets
Shattil, S. J., & Newman, P. J. (2004) · Blood · doi:10.1182/blood-2004-04-1257 · Cited by 601
Moake, J. L., Turner, N. A., Stathopoulos, N. A., Nolasco, L. H., & Hellums, J. D. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112736 · Cited by 599
PI 3-kinase p110β: a new target for antithrombotic therapy
Jackson, S. P., Schoenwaelder, S. M., Goncalves, I., Nesbitt, W. S., Yap, C. L., Wright, C. E., Kenche, V., Anderson, K. E., Dopheide, S. M., Yuan, Y., et al. (2005) · Nature Medicine · doi:10.1038/nm1232 · Cited by 580
How the protease thrombin talks to cells
Coughlin, S. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11023 · Cited by 576
Molecular Basis for ADP-induced Platelet Activation
Jin, J., Daniel, J. L., & Kunapuli, S. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2030 · Cited by 477
Wallentin, L., Varenhorst, C., James, S., Erlinge, D., Braun, O. O., Jakubowski, J. A., Sugidachi, A., Winters, K. J., & Siegbahn, A. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm545 · Cited by 457
Hennekens, C. H., Dyken, M. L., & Fuster, V. (1997) · Circulation · doi:10.1161/01.cir.96.8.2751 · Cited by 435
Stalker, T. J., Traxler, E. A., Wu, J., Wannemacher, K. M., Cermignano, S. L., Voronov, R., Diamond, S. L., & Brass, L. F. (2013) · Blood · doi:10.1182/blood-2012-09-457739 · Cited by 427
Activation-independent platelet adhesion and aggregation under elevated shear stress
Ruggeri, Z. M., Orje, J. N., Habermann, R., Federici, A. B., & Reininger, A. J. (2006) · Blood · doi:10.1182/blood-2006-04-011551 · Cited by 415
Wallentin, L. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp296 · Cited by 409
Antiplatelet therapies for the treatment of cardiovascular disease
Michelson, A. D. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2957 · Cited by 407
Bleeding, Blood Transfusion, and Increased Mortality After Percutaneous Coronary Intervention
Doyle, B. J., Rihal, C. S., Gastineau, D. A., & Holmes, D. R. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.073 · Cited by 392
Structure and function of the platelet integrin IIb 3
Bennett, J. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26989 · Cited by 358
Novel antiplatelet agents in acute coronary syndrome
Franchi, F., & Angiolillo, D. J. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.156 · Cited by 353
Structure and Function of von Willebrand Factor
Ruggeri, Z. M. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615883 · Cited by 332
A critical role for extracellular protein disulfide isomerase during thrombus formation in mice
Cho, J., Furie, B. C., Coughlin, S. R., & Furie, B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34134 · Cited by 324
Westein, E., van der Meer, A. D., Kuijpers, M. J. E., Frimat, J.-P., van den Berg, A., & Heemskerk, J. W. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209905110 · Cited by 304
Rao, S. V., Eikelboom, J. A., Granger, C. B., Harrington, R. A., Califf, R. M., & Bassand, J.-P. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm019 · Cited by 275
Current Role of Platelet Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes
Bhatt, D. L. (2000) · JAMA · doi:10.1001/jama.284.12.1549 · Cited by 269
RUGGERI, Z. M. (2009) · Microcirculation · doi:10.1080/10739680802651477 · Cited by 253
Ungerer, M., Rosport, K., Bültmann, A., Piechatzek, R., Uhland, K., Schlieper, P., Gawaz, M., & Münch, G. (2011) · Circulation · doi:10.1161/circulationaha.110.980623 · Cited by 245
Bergmeier, W., Piffath, C. L., Goerge, T., Cifuni, S. M., Ruggeri, Z. M., Ware, J., & Wagner, D. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608207103 · Cited by 233
Peter, K., Schwarz, M., Ylänne, J., Kohler, B., Moser, M., Nordt, T., Salbach, P., Kübler, W., & Bode, C. (1998) · Blood · doi:10.1182/blood.v92.9.3240 · Cited by 229
Self-citationCell signalling through thromboxane A2 receptors
Huang, J. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2003.10.008 · Cited by 227
Ohman, E. M., Roe, M. T., Steg, P. G., James, S. K., Povsic, T. J., White, J., Rockhold, F., Plotnikov, A., Mundl, H., Strony, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30751-1 · Cited by 223
Erlinge, D., Varenhorst, C., Braun, O. Ö., James, S., Winters, K. J., Jakubowski, J. A., Brandt, J. T., Sugidachi, A., Siegbahn, A., & Wallentin, L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.068 · Cited by 215
Integrins in platelet activation
NIESWANDT, B., VARGA-SZABO, D., & ELVERS, M. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03370.x · Cited by 214
Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling
Ishii, K., Hein, L., Kobilka, B., & Coughlin, S. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98415-2 · Cited by 205
A directional switch of integrin signalling and a new anti-thrombotic strategy
Shen, B., Zhao, X., O’Brien, K. A., Stojanovic-Terpo, A., Delaney, M. K., Kim, K., Cho, J., Lam, S. C.-T., & Du, X. (2013) · Nature · doi:10.1038/nature12613 · Cited by 200
Serebruany, V. L., Malinin, A. I., Eisert, R. M., & Sane, D. C. (2004) · American Journal of Hematology · doi:10.1002/ajh.10451 · Cited by 198
Welsh, J. D., Stalker, T. J., Voronov, R., Muthard, R. W., Tomaiuolo, M., Diamond, S. L., & Brass, L. F. (2014) · Blood · doi:10.1182/blood-2014-01-550335 · Cited by 185
Ulrichts, H., Silence, K., Schoolmeester, A., de Jaegere, P., Rossenu, S., Roodt, J., Priem, S., Lauwereys, M., Casteels, P., Van Bockstaele, F., et al. (2011) · Blood · doi:10.1182/blood-2010-11-317859 · Cited by 184
Kim, K., Hahm, E., Li, J., Holbrook, L.-M., Sasikumar, P., Stanley, R. G., Ushio-Fukai, M., Gibbins, J. M., & Cho, J. (2013) · Blood · doi:10.1182/blood-2013-03-492504 · Cited by 183
Stalker, T. J., Welsh, J. D., Tomaiuolo, M., Wu, J., Colace, T. V., Diamond, S. L., & Brass, L. F. (2014) · Blood · doi:10.1182/blood-2014-01-550319 · Cited by 181
Deo, S. V., Dunlay, S. M., Shah, I. K., Altarabsheh, S. E., Erwin, P. J., Boilson, B. A., Park, S. J., & Joyce, L. D. (2013) · Journal of Cardiac Surgery · doi:10.1111/jocs.12074 · Cited by 171
Platelet GPVI: a target for antithrombotic therapy?!
Dütting, S., Bender, M., & Nieswandt, B. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.07.004 · Cited by 159
Wong, P. C., Seiffert, D., Bird, J. E., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf5294 · Cited by 157
Duerschmied, D., Merhi, Y., Tanguay, J., Hutabarat, R. M., GILBERT, J., Wagner, D. D., Schaub, R. G., Diener, J. L., & Lagassé, H. A. D. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03459.x · Cited by 156
Martin, V., Guillermet‐Guibert, J., Chicanne, G., Cabou, C., Jandrot‐Perrus, M., Plantavid, M. M., Vanhaesebroeck, B., Payrastre, B., & Gratacap, M. (2010) · Blood · doi:10.1182/blood-2009-04-217224 · Cited by 154
Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRγ deficiency
Mangin, P., Yap, C. L., Nonne, C., Sturgeon, S. A., Goncalves, I., Yuan, Y., Schoenwaelder, S. M., Wright, C. E., Lanza, F., & Jackson, S. P. (2006) · Blood · doi:10.1182/blood-2005-10-4244 · Cited by 152
Nylander, S., Kull, B., Björkman, J., Ulvinge, J.-C., Oakes, N. D., Emanuelsson, B. ‐., ANDERSSON, M., Skärby, T., Inghardt, T., Fjellström, O., et al. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04898.x · Cited by 150
Lei, X., Adili, R., Hou, Y., Zhou, H., Wang, Y., Marshall, A. H., Liang, C., Dai, X., Li, B. X., Vanhoorelbeke, K., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-06-0490 · Cited by 140
Targeting Integrin and Integrin Signaling in Treating Thrombosis
Estevez, B., Shen, B., & Du, X. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303411 · Cited by 134
Baber, U., Dangas, G., Cohen, D. J., Gibson, C. M., Mehta, S. R., Angiolillo, D. J., Pocock, S., Krucoff, M. W., Kastrati, A., Ohman, E. M., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.09.006 · Cited by 125
The von Willebrand Inhibitor ARC1779 Reduces Cerebral Embolization After Carotid Endarterectomy
Markus, H. S., McCollum, C. N., Imray, C., Goulder, M. A., Gilbert, J., & King, A. (2011) · Stroke · doi:10.1161/strokeaha.111.616649 · Cited by 119
GPIIb/IIIa inhibitors: From bench to bedside and back to bench again
Armstrong, P. C. J., & Peter, K. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-10-0727 · Cited by 116
Self-citationBender, M., Hagedorn, I., & Nieswandt, B. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04328.x · Cited by 109
Vranckx, P., Valgimigli, M., Windecker, S., Steg, P. G., Hamm, C. W., Jüni, P., García‐García, H. M., van Es, G., & Serruys, P. W. J. C. (2016) · EuroIntervention · doi:10.4244/eijy15m11_07 · Cited by 109
Thrombin generation and atherosclerosis
Kalz, J., Cate, H. T., & Spronk, H. M. H. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-1026-5 · Cited by 107
Platelet PI3Kβ and GSK3 regulate thrombus stability at a high shear rate
Laurent, P.-A., Séverin, S., Hechler, B., Vanhaesebroeck, B., Payrastre, B., & Gratacap, M. (2014) · Blood · doi:10.1182/blood-2014-07-588335 · Cited by 106
Thiol Isomerases in Thrombus Formation
Furie, B., & Flaumenhaft, R. C. (2014) · Circulation Research · doi:10.1161/circresaha.114.301808 · Cited by 106
The evolution of antiplatelet therapy in cardiovascular disease
Yousuf, O. K., & Bhatt, D. L. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.96 · Cited by 105
Flaumenhaft, R. C., & Ceunynck, K. D. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.05.001 · Cited by 103
Regulation and roles of PI3Kβ, a major actor in platelet signaling and functions
Gratacap, M., Guillermet‐Guibert, J., Martin, V., Chicanne, G., Tronchère, H., Gaits‐Iacovoni, F., & Payrastre, B. (2010) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2010.09.011 · Cited by 102
Silvain, J., Abtan, J., Kernéis, M., Martin, R., Finzi, J., Vignalou, J.-B., Barthélémy, O., O’Connor, S. A., Luyt, C. E., Bréchot, N., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.029 · Cited by 98
Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxar
Aisiku, O. R., Peters, C. G., Ceunynck, K. D., Ghosh, C. C., Dilks, J. R., Fustolo‐Gunnink, S. F., Huang, M., Dockendorff, C., Parikh, S. M., & Flaumenhaft, R. C. (2015) · Blood · doi:10.1182/blood-2014-09-599910 · Cited by 96
Novel Antiplatelet Agents: ALX-0081, a Nanobody Directed towards von Willebrand Factor
Bartúnek, J., Barbato, E., Heyndrickx, G. R., Vanderheyden, M., Wijns, W. C., & Holz, J.-B. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9435-y · Cited by 95
Towards a standardization of the murine tail bleeding model
Greene, T. K., Schiviz, A. N., Hoellriegl, W., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04084.x · Cited by 90
Li, J., Vootukuri, S., Shang, Y., Negri, A., Jiang, J., Nedelman, M. A., Diacovo, T. G., Filizola, M., Thomas, C. J., & Coller, B. S. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303724 · Cited by 90
Towards Effective and Safe Thrombolysis and Thromboprophylaxis
Wang, X., Palasubramaniam, J., Gkanatsas, Y., Hohmann, J. D., Westein, E., Kanojia, R., Alt, K., Huang, D., Jia, F., Ahrens, I., et al. (2014) · Circulation Research · doi:10.1161/circresaha.114.302514 · Cited by 88
Self-citationBassler, N., Loeffler, C., Mangin, P., Yuan, Y., Schwarz, M., Hagemeyer, C. E., Eisenhardt, S. U., Ahrens, I., Bode, C., Jackson, S. P., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000255307.65939.59 · Cited by 86
Self-citationStoll, P., Bassler, N., Hagemeyer, C. E., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.106.138875 · Cited by 85
New Directions in Antiplatelet Therapy
Ferreiro, J. L., & Angiolillo, D. J. (2012) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.111.966176 · Cited by 80
Cangrelor: a review on pharmacology and clinical trial development
Franchi, F., Rollini, F., Muñiz‐Lozano, A., Cho, J. R., & Angiolillo, D. J. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.837701 · Cited by 78
Bosch, X., Marrugat, J., & Sanchis, J. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002130.pub4 · Cited by 69
Bergmeier, W., Piffath, C. L., Goerge, T., Cifuni, S. M., Ruggeri, Z. M., Ware, J. L., & Wagner, D. D. (2006) · Blood · doi:10.1182/blood.v108.11.1797.1797 · Cited by 68
Ducrocq, G., Schulte, P. J., Becker, R. C., Cannon, C. P., Harrington, R. A., Held, C., Himmelmänn, A., Lassila, R., Storey, R. F., Sorbets, E., et al. (2015) · EuroIntervention · doi:10.4244/eijy14m09_11 · Cited by 64
Decreased Thrombotic Tendency in Mouse Models of the Bernard-Soulier Syndrome
Strassel, C., Nonne, C., Eckly, A. E., David, T., Léon, C., Freund, M., Cazenave, J., Gachet, C., & Lanza, F. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000251992.47053.75 · Cited by 61
Antithrombotics in Acute Coronary Syndromes
Bonaca, M. P., Steg, P. G., Feldman, L. J., Canales, J. F., Ferguson, J. J., Wallentin, L. C., Califf, R. M., Harrington, R. A., & Giugliano, R. P. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.083 · Cited by 60
Nylander, S., Wågberg, F., Andersson, M., Skärby, T., & Gustafsson, D. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13027 · Cited by 57
Differentiating haemostasis from thrombosis for therapeutic benefit
McFadyen, J. D., & Jackson, S. P. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-05-0379 · Cited by 54
Self-citationDesign and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro
Muzard, J., Bouabdelli, M., Zahid, M., Ollivier, V., Lacapère, J.-J., Jandrot‐Perrus, M., & Billiald, P. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07129.x · Cited by 36
Cited by
Platelet biology and functions: new concepts and clinical perspectives
van der Meijden, P. E. J., & Heemskerk, J. W. M. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0110-0 · Cited by 1,041
A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes
Flora, G. D., & Nayak, M. K. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190925163827 · Cited by 476
ST-segment elevation myocardial infarction
Vogel, B., Claessen, B. E., Arnold, S. V., Chan, D., Cohen, D. J., Giannitsis, E., Gibson, C. M., Goto, S., Katus, H. A., Kerneis, M., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0090-3 · Cited by 419
Interplay between platelets and coagulation
Sang, Y., Roest, M., de Laat, B., de Groot, P. G., & Huskens, D. (2021) · Blood Reviews · doi:10.1016/j.blre.2020.100733 · Cited by 405
Therapeutic strategies for thrombosis: new targets and approaches
Mackman, N., Bergmeier, W., Stouffer, G. A., & Weitz, J. I. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0061-0 · Cited by 388
Metadata
- Authors
- McFadyen, J. D., Schaff, M., & Peter, K.
- Venue
- Nature Reviews Cardiology
- Published
- 2018-01-03
- Volume
- 15
- Issue
- 3
- Pages
- 181-191
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W2782280176
- Cited by
- 281
- References
- 104
- FWCI
- 8.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.